Australia, Oct. 22 -- Aborns Pharmaceuticals Pty. Ltd., owns the trademark (2633009) for 'Xdenva' till March 13, 2036.

Status: registered: Registered/protected

Class: 5 [pharmaceutical preparations for the treatment of musculoskeletal disorders; pharmaceutical drugs; pharmaceuticals; pharmaceutical preparations and substances; pharmaceutical products and preparations; pharmaceutical preparations; pharmaceutical preparations for human purposes; pharmaceutical products for use by humans; pharmaceutical preparations for human use; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the musculoskeletal system; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceuticals for the prevention and treatment of cancer; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of bone diseases; pharmaceuticals for the treatment of cancer; pharmaceutical preparations for suppressing tumors; biochemical drug]

Type of Mark: Word

Date of Acceptance: March 27

Registration Advertised: Oct. 21

For further details contact Aborns Pharmaceuticals Pty. Ltd. .

The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2633009.

Disclaimer: Curated by HT Syndication.